about
Shortcomings in the current treatment of epilepsySeizure prognosis in brain tumors: new insights and evidence-based managementGlycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: an update.Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome.Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies.The relationship between pharmacokinetic parameters of carbamazepine and therapeutic response in epileptic patients.Eslicarbazepine acetate for partial-onset seizures.Lacosamide for the treatment of partial-onset seizures.Methodologies used to identify and characterize interactions among antiepileptic drugs.Medical management of refractory epilepsy--practical treatment with novel antiepileptic drugs.Network meta-analyses of antiepileptic drug efficacy and tolerability in drug-resistant focal epilepsies: a clinical perspective.Refractory epilepsy in children.USL255 extended-release topiramate for the treatment of epilepsy.Seizures in oligodendroglial tumors.Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.Effects of arachidonyl-2'-chloroethylamide (ACEA) on the protective action of various antiepileptic drugs in the 6-Hz corneal stimulation model in mice.Sodium Channel Blockers in the Treatment of Epilepsy.The importance of assessing behaviour and cognition in antiepileptic drug trials in children and adolescents.Pharmacological Treatment of Drug-Resistant Epilepsy in Adults: a Practical Guide.Computational approaches for innovative antiepileptic drug discovery.Tolerability and Safety of Commonly Used Antiepileptic Drugs in Adolescents and Adults: A Clinician's Overview.Effect of phenytoin on sodium conductances in rat hippocampal CA1 pyramidal neurons.Lacosamide use in children with epilepsy: Retention rate and effect of concomitant sodium channel blockers in a large cohort.Therapeutic Outcomes and Prognostic Factors in Childhood Absence Epilepsy.Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures.Drug utilization profile in adult patients with refractory epilepsy at a tertiary referral center.Beneficial Combination of Lacosamide with Retigabine in Experimental Animals: An Isobolographic Analysis.Outcome of cancer-related seizures in patients treated with lacosamide.[Epilepsy-new diagnostic tools, old drugs? : Therapeutic consequences of epilepsy genetics].
P2860
Q22305925-CF3A935D-8EF9-49BE-84C9-F2F67FFDC68FQ33829789-2CDAA44A-224A-4A8D-8111-FA8C9B659C33Q34381226-376645F8-7560-4468-A3BC-DD6E78C86490Q35664957-1B598835-DC61-46B5-9D6E-F67ED620B178Q35761335-38AF8B3E-2051-467E-B610-BB461E0AADE2Q36031424-B86D3114-023B-4A72-947F-930E94DF5E9AQ36776559-AF236E4B-73AC-474A-9637-CB630E39942AQ36943913-0249E5D7-DFF7-41EE-81F8-C1870D0C759AQ37113376-70B06126-30F6-4365-AC5C-9DE79EA65015Q37675543-E75CA08F-D431-4145-983C-63C8962A4FD2Q37957121-E2CFCFBF-5926-4D50-B9E4-E1D7D6D197BDQ38014885-9AFCEDB3-24A5-421D-B02E-02BD83324AD8Q38018676-34A02AEC-A5C7-4710-868A-7B613AF0FBB7Q38176649-098D66A6-D437-4D2A-A5BA-259B10709774Q38199973-CE980978-9962-45DE-820D-7E7826980B14Q38238262-B543260B-6C31-41F8-8EAB-3C4802CC54B4Q38249142-1A56000A-623E-45C1-8072-A4A0DE31AD62Q38610571-AB8314F7-2F93-49F6-AC53-A3338B4582D8Q38617833-C287D95B-C091-47A2-A120-4E677DD10EB9Q38634921-BE47D46B-7D9F-4655-8531-6CE99896E709Q38775516-B17FA83A-9C81-4F2E-B6E3-0CA1D2569605Q38779934-F1FA3568-EABA-49DD-9DBC-8BDA4D751018Q38904679-9BA64F23-3423-4BFD-A259-6F510D9A67BBQ38907478-98FFD773-AF13-4B2F-9DE0-308F29E0F578Q39094490-0A5DB50C-9125-4A0F-83DD-B2387D7B19DCQ39526525-5EE08510-1766-47BC-82DC-81D26F41DAA4Q39588734-ACD37833-2ABA-45EB-B2F6-5317DA9A02F8Q40064905-A2DBD0BB-A4F7-4030-AF3E-0F9DDFDEAD69Q44168300-064873FC-771B-4399-9D6C-2FECCE926CB4Q45393223-564B32CF-31A0-4A92-BE04-CD1F39A71A33Q48105985-7C353DE4-7C5F-4D45-8D75-07F3E1D0CBACQ48143454-80114230-24AC-43FD-8D65-D7CDBBE877CCQ49971762-0AC4262F-93AB-4448-A821-1EDCCA2A1B98
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Combining antiepileptic drugs--rational polytherapy?
@en
Combining antiepileptic drugs--rational polytherapy?
@nl
type
label
Combining antiepileptic drugs--rational polytherapy?
@en
Combining antiepileptic drugs--rational polytherapy?
@nl
prefLabel
Combining antiepileptic drugs--rational polytherapy?
@en
Combining antiepileptic drugs--rational polytherapy?
@nl
P1476
Combining antiepileptic drugs--rational polytherapy?
@en
P304
P356
10.1016/J.SEIZURE.2011.01.004
P577
2011-02-08T00:00:00Z